Welcome to Snoretox Ltd.
Inventing a drug to resolve BOAS (Brachycephalic Obstructive Airways Syndrome) along with human muscle weakness conditions.
We're Finalists in 2025!
The annual Animal Health, Nutrition and Technology Innovation event is the global premier investment forum showcasing the most exciting investment opportunities in animal health and nutrition. It connects those businesses with financial investors and strategic corporate partners.
Competition for selection as a Showcase finalist is intense. There were 8 international selection committee members who have an extensive breadth of experience and knowledge across animal health and nutrition industries.
After a 5-minute presentation, the audience will select a winner.
Selection as a Showcase Finalist alone is significant recognition by experts in the field of the potential of Snoretox products for the treatment of BOAS and other conditions in the Veterinarian sector.
Our timeline to success
2025
2024
2022
Snoretox was today singled out in the announcement $100 million for the Breakthrough Victoria – University Innovation Platform.
‘Snoretox is another example of a company commercialising RMIT-developed technology – a novel muscle toning toxin-based therapeutic for treating sleep apnea and snoring, as well as a range of other weak muscle conditions such as incontinence.’
2021
Snoretox wins a Medical Research Future Fund (MRFF) 2021 Frontier Health and Medical Research Initiative Grant, securing a $1 million grant.
The MRFF is a 20 Billion dollar fund set up by the Australian Federal Government to promote medical research and it’s translation to the clinic.
2020
2020
First Scientific Publication: Molecular Immunology. Volume 127. November 2020
In the laboratories of RMIT University, in Melbourne, Australia, we have invented and patented the world’s first effective and long-lasting drug for muscle weakness.
Our game-changing technology is based on molecules of tetanus toxin, modified to ensure they work around the tetanus vaccine.
Just as Botox uses tiny amounts of botulinum toxin to relax muscles, our prototype therapeutic uses minute amounts of tetanus toxin to achieve the opposite effect – muscle toning.
Snoretox dogs are happy dogs!
Novel modified tetanus toxin muscle toning biotherapeutics for:
- BOAS
- Sleep apnoea and snoring
- Muscle recovery
- Sphincter weakness (anal, oesophageal, bladder, pelvic floor)
- Neurological (Multiple Sclerosis, Motor Neuron Disease, Myopathy)
- Veterinary (sleep apnoea, “roaring” larynx disorders, sphincter incontinence, muscle weakness)
- Cosmetic muscle toning (eyelid issues such as ectropion and ptosis, facial and chin lifting, general muscle toning)
Our therapeutics are trademarked SnoretoxTM (for sleep apnoea) and TonetoxTM (for other applications).
